CRL
Charles River Laboratories International, Inc.
Stock
$290.19+3.36 (+1.17%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $4.0B | +6.5% |
| Gross profit | $1.1B | +12.5% |
| Operating income | $90M | −43.4% |
| Net income | −$238M | — |
| EPS | −$4.91 | — |
| Free cash flow | $371M | +6.4% |